News
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...
A recent study revealed that individuals taking weight-loss drugs, including renowned GLP-1s, may significantly regain weight ...
In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Weight loss injections could help to reduce asthma symptoms in obese people, according to researchers at the University of ...
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
As Medicare turns 60, Medscape convened an expert panel to discuss if physicians can survive without the program and the ways ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results